Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Isotopes (5)
- Biological Systems (1)
- Biology and Environment (30)
- Clean Energy (25)
- Computational Biology (2)
- Computational Engineering (2)
- Fusion and Fission (2)
- Materials (42)
- Materials for Computing (7)
- Mathematics (1)
- National Security (6)
- Neutron Science (100)
- Nuclear Science and Technology (7)
- Supercomputing (26)
News Topics
- (-) Biomedical (5)
- (-) Neutron Science (2)
- 3-D Printing/Advanced Manufacturing (22)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Bioenergy (1)
- Climate Change (1)
- Composites (3)
- Computer Science (2)
- Cybersecurity (1)
- Energy Storage (1)
- Environment (1)
- Fusion (1)
- Irradiation (1)
- Isotopes (24)
- Machine Learning (1)
- Materials (10)
- Materials Science (7)
- National Security (1)
- Nuclear Energy (5)
- Security (1)
- Space Exploration (5)
- Sustainable Energy (5)
- Transformational Challenge Reactor (1)
Media Contacts
Scientists at ORNL have developed 3D-printed collimator techniques that can be used to custom design collimators that better filter out noise during different types of neutron scattering experiments
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
The ExOne Company, the global leader in industrial sand and metal 3D printers using binder jetting technology, announced it has reached a commercial license agreement with Oak Ridge National Laboratory to 3D print parts in aluminum-infiltrated boron carbide.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.